La Jolla, CA, United States of America

Jin-You Xu


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Jin-You Xu in Synthetic Chemistry

Introduction

Jin-You Xu is a prominent inventor based in La Jolla, CA (US). He has made significant contributions to the field of synthetic chemistry, particularly in the development of bioactive compounds. His work has implications for cancer treatment and drug development.

Latest Patents

Jin-You Xu holds 1 patent for his invention titled "Analogs of sarcodictyin and eleutherobin." This patent describes the synthesis of Sarcodictyin A and B, eleutherobin, and their bioactive analogs using solid phase and solution phase chemistries. The synthetic method involves the attachment of common precursors on a solid support to generate conjugates, followed by standard chemical manipulations. A combinatorial library of sarcodictyins and eleutherobin analogs was constructed, which was screened for activity against tubulin polymerization and cytotoxic activity against tumor cells, including Taxol-resistant lines. Notably, several compounds were identified to exhibit equal or superior biological activities compared to their natural counterparts.

Career Highlights

Jin-You Xu is affiliated with The Scripps Research Institute, where he has been involved in groundbreaking research. His innovative approaches in synthetic chemistry have positioned him as a key figure in the development of new therapeutic agents.

Collaborations

Throughout his career, Jin-You Xu has collaborated with esteemed colleagues, including Kyriacos Costa Nicolaou and Floris VanDelft. These collaborations have further enhanced the impact of his research in the scientific community.

Conclusion

Jin-You Xu's contributions to synthetic chemistry and his innovative patent on bioactive analogs highlight his role as a leading inventor in the field. His work continues to influence cancer research and drug development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…